Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2021 Filed May 4, 2021 21:04 UTC |
LeCointe-Cephas LisaSVP Chief Ethics & Com Officer
|
Tax withholdingCommon Stock | 210 | $74.50 | $15,645.00 |
DisclosureSEC source: 0001127602-21-015279 · form4.xml · nonDerivative · entry 2 LeCointe-Cephas Lisa · CIK 0001854644 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,631.346 Read SEC document |
| May 01, 2021 Filed May 4, 2021 21:04 UTC |
LeCointe-Cephas LisaSVP Chief Ethics & Com Officer
|
Exercise / conversionCommon Stock | 622 | $74.50 | $46,339.00 |
DisclosureSEC source: 0001127602-21-015279 · form4.xml · nonDerivative · entry 1 LeCointe-Cephas Lisa · CIK 0001854644 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,841.346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 18:51 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 421.5852 | $77.09 | $32,500.00 |
DisclosureSEC source: 0001127602-21-012550 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,337.1857 Underlying: Common Stock · 421.5852 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 18:55 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 210.7926 | $77.09 | $16,250.00 |
DisclosureSEC source: 0001127602-21-012552 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,509.5508 Underlying: Common Stock · 210.7926 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 19:03 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 389.1555 | $77.09 | $30,000.00 |
DisclosureSEC source: 0001127602-21-012554 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,545.2497 Underlying: Common Stock · 389.1555 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 13:47 UTC |
Mayo StephenDirector
|
GrantPhantom Stock · Derivative | 119.8975 | $76.23 | $9,139.79 |
DisclosureSEC source: 0001127602-21-010907 · form4.xml · derivative · entry 2 Mayo Stephen · CIK 0001849061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119.8975 Underlying: Common Stock · 119.8975 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:14 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantCommon Stock | 175,249 | $72.62 | $12,726,582.38 |
DisclosureSEC source: 0001127602-21-008561 · form4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,795.063 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:35 UTC |
Fleming MichaelSVP Chief Ethics & Com Officer
|
GrantCommon Stock | 3,437 | $72.62 | $249,594.94 |
DisclosureSEC source: 0001127602-21-008565 · form4.xml · nonDerivative · entry 1 Fleming Michael · CIK 0001772183 · SVP Chief Ethics & Com Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,283.334 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:39 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
GrantCommon Stock | 7,127 | $72.62 | $517,562.74 |
DisclosureSEC source: 0001127602-21-008567 · form4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,630.091 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:41 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
GrantCommon Stock | 9,432 | $72.62 | $684,951.84 |
DisclosureSEC source: 0001127602-21-008569 · form4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,588.769 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:44 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
GrantCommon Stock | 25,772 | $72.62 | $1,871,562.64 |
DisclosureSEC source: 0001127602-21-008571 · form4.xml · nonDerivative · entry 1 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,145.357 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:46 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
GrantCommon Stock | 12,585 | $72.62 | $913,922.70 |
DisclosureSEC source: 0001127602-21-008573 · form4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,162.138 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:48 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Heallth
|
GrantCommon Stock | 25,510 | $72.62 | $1,852,536.20 |
DisclosureSEC source: 0001127602-21-008575 · form4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Heallth 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,051.694 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:50 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
GrantCommon Stock | 46,641 | $72.62 | $3,387,069.42 |
DisclosureSEC source: 0001127602-21-008577 · form4.xml · nonDerivative · entry 1 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,696.757 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:51 UTC |
Zachary JenniferEVP, General Counsel
|
GrantCommon Stock | 24,199 | $72.62 | $1,757,331.38 |
DisclosureSEC source: 0001127602-21-008579 · form4.xml · nonDerivative · entry 1 Zachary Jennifer · CIK 0001737231 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,947.115 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 5/04/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:54 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
GrantCommon Stock | 17,830 | $72.62 | $1,294,814.60 |
DisclosureSEC source: 0001127602-21-008581 · form4.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,181.145 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 10/30/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:56 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
GrantCommon Stock | 6,052 | $72.62 | $439,496.24 |
DisclosureSEC source: 0001127602-21-008583 · form4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,835.972 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 16:57 UTC |
Williams David MichaelEVP,Chief Info&Digital Officer
|
GrantCommon Stock | 2,090 | $72.62 | $151,775.80 |
DisclosureSEC source: 0001127602-21-008585 · form4.xml · nonDerivative · entry 1 Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,582.883 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 17:00 UTC |
Li Dean YExecutive VP & President, MRL
|
GrantCommon Stock | 3,485 | $72.62 | $253,080.70 |
DisclosureSEC source: 0001127602-21-008587 · form4.xml · nonDerivative · entry 1 Li Dean Y · CIK 0001837016 · Executive VP & President, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,655.093 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/29/18. Performance shares were paid out at 166 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2020. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 10, 2021 Filed Feb 11, 2022 21:11 UTC |
Williams David MichaelEVP,Chief Info&Digital Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004553 · form4.xml · derivative · entry 3 Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,335 Underlying: Common Stock · 1,167 shares Expires 2023-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 2/10/2021, 2/10/2022 and 2/10/2023. F4 · balance_after: Holdings were adjusted to 2,407 as of June 2, 2021 in connection with the Organon & Co. ("Organon") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the "Form 10"). As reported in the Form 10, all Merck time-based restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments. Read SEC document |
| February 10, 2021 Filed Feb 11, 2022 21:11 UTC |
Williams David MichaelEVP,Chief Info&Digital Officer
|
Tax withholdingCommon Stock | 467 | $75.04 | $35,043.68 |
DisclosureSEC source: 0001127602-22-004553 · form4.xml · nonDerivative · entry 2 Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,192.883 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions; reflects holdings as of February 10, 2021. Read SEC document |
| February 10, 2021 Filed Feb 11, 2022 21:11 UTC |
Williams David MichaelEVP,Chief Info&Digital Officer
|
Exercise / conversionCommon Stock | 1,167 | $75.04 | $87,571.68 |
DisclosureSEC source: 0001127602-22-004553 · form4.xml · nonDerivative · entry 1 Williams David Michael · CIK 0001820958 · EVP,Chief Info&Digital Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,659.883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:23 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 366.7482 | $81.80 | $30,000.00 |
DisclosureSEC source: 0001127602-21-000534 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,380.9612 Underlying: Common Stock · 366.7482 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:24 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 198.6552 | $81.80 | $16,250.00 |
DisclosureSEC source: 0001127602-21-000543 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,274.6782 Underlying: Common Stock · 198.6552 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:27 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 397.3105 | $81.80 | $32,500.00 |
DisclosureSEC source: 0001127602-21-000550 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857.2005 Underlying: Common Stock · 397.3105 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:45 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 144,866 | $81.74 | $11,840,941.22 |
DisclosureSEC source: 0001127602-20-028825 · form4.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,546.063 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.40 to $82.33, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 21:45 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
SaleCommon Stock | 135,134 | $81.08 | $10,956,070.13 |
DisclosureSEC source: 0001127602-20-028825 · form4.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,412.063 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.41 to $81.39, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:44 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-028032 · form4.xml · derivative · entry 3 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,575 Underlying: Common Stock · 4,574 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F3 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:44 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 2,273 | $75.89 | $172,497.97 |
DisclosureSEC source: 0001127602-20-028032 · form4.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,351.145 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:44 UTC |
MIZELL STEVENEVP, Chief HR Officer
|
Exercise / conversionCommon Stock | 4,574 | $75.89 | $347,120.86 |
DisclosureSEC source: 0001127602-20-028032 · form4.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,624.145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:48 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-028034 · form4.xml · derivative · entry 4 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Common Stock · 2,287 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:48 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Tax withholdingCommon Stock | 995 | $75.89 | $75,510.55 |
DisclosureSEC source: 0001127602-20-028034 · form4.xml · nonDerivative · entry 2 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,407.936 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:48 UTC |
Nally MichaelEVP, Chief Marketing Officer
|
Exercise / conversionCommon Stock | 2,287 | $75.89 | $173,560.43 |
DisclosureSEC source: 0001127602-20-028034 · form4.xml · nonDerivative · entry 1 Nally Michael · CIK 0001763945 · EVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,402.936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:55 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-028036 · form4.xml · derivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Common Stock · 2,287 shares Expires 2021-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. F4 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:55 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,137 | $75.89 | $86,286.93 |
DisclosureSEC source: 0001127602-20-028036 · form4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,518.801 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 21:55 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,287 | $75.89 | $173,560.43 |
DisclosureSEC source: 0001127602-20-028036 · form4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,655.801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2020 Filed Feb 9, 2021 21:27 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GiftCommon Stock | 64,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004702 · form5.xml · nonDerivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,546.063 F1 · balance_after: Amount reported reflects the number of shares beneficially owned at the end of fiscal year 2020, taking into account all transactions reported here and the sale transactions reported on Form 4 filed on November 12, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:52 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 251,273 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001127602-20-026617 · form4.xml · derivative · entry 3 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 251,273 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:52 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
SaleCommon Stock | 251,273 | $81.03 | $20,360,324.54 |
DisclosureSEC source: 0001127602-20-026617 · form4.xml · nonDerivative · entry 2 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,055.757 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.62 to $81.42, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 20:52 UTC |
Davis Robert MEVP, Global Svcs & CFO
|
Exercise / conversionCommon Stock | 251,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026617 · form4.xml · nonDerivative · entry 1 Davis Robert M · CIK 0001363076 · EVP, Global Svcs & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,328.757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:07 UTC |
Coe Mary EllenDirector
|
GrantPhantom Stock · Derivative | 391.8023 | $82.95 | $32,500.00 |
DisclosureSEC source: 0001127602-20-026321 · form4.xml · derivative · entry 2 Coe Mary Ellen · CIK 0001691304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,406.4313 Underlying: Common Stock · 391.8023 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:20 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 361.6637 | $82.95 | $30,000.00 |
DisclosureSEC source: 0001127602-20-026340 · form4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,268.0497 Underlying: Common Stock · 361.6637 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:23 UTC |
Seidman Christine EDirector
|
GrantPhantom Stock · Derivative | 195.9011 | $82.95 | $16,250.00 |
DisclosureSEC source: 0001127602-20-026349 · form4.xml · derivative · entry 2 Seidman Christine E · CIK 0001805745 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,054.2401 Underlying: Common Stock · 195.9011 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| September 17, 2020 Filed Feb 9, 2021 21:27 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GiftCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004702 · form5.xml · nonDerivative · entry 2 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,546.063 F1 · balance_after: Amount reported reflects the number of shares beneficially owned at the end of fiscal year 2020, taking into account all transactions reported here and the sale transactions reported on Form 4 filed on November 12, 2020. Read SEC document |
| August 25, 2020 Filed Feb 9, 2021 21:27 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-004702 · form5.xml · nonDerivative · entry 1 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,546.063 F1 · balance_after: Amount reported reflects the number of shares beneficially owned at the end of fiscal year 2020, taking into account all transactions reported here and the sale transactions reported on Form 4 filed on November 12, 2020. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 22:36 UTC |
Chattopadhyay SanatExe V-P & Pres. MMD
|
SaleCommon Stock | 10,380 | $83.01 | $861,675.98 |
DisclosureSEC source: 0001127602-20-023725 · form4.xml · nonDerivative · entry 1 Chattopadhyay Sanat · CIK 0001670690 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,373.357 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.99 to $83.05, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:53 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,876 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001127602-20-023070 · form4.xml · derivative · entry 4 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,876 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:53 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
SaleCommon Stock | 18,876 | $81.55 | $1,539,273.62 |
DisclosureSEC source: 0001127602-20-023070 · form4.xml · nonDerivative · entry 2 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,763.106 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.5400 to $81.5550, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:53 UTC |
Clyburn FrankEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 18,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-023070 · form4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,639.106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2020 Filed Jul 20, 2020 20:53 UTC |
Gerberding Julie L.EVP Strat Comm, GI Pub Policy
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,111 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001127602-20-021823 · form4.xml · derivative · entry 4 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, GI Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,111 shares Expires 2026-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.